Suppr超能文献

[高剂量口服镁剂治疗心律失常。1160例心律失常患者的观察性研究结果]

[High-dosage oral magnesium therapy in arrhythmias. Results of an observational study in 1.160 patients with arrhythmia].

作者信息

Holzgartner H, Maier E, Vierling W

机构信息

Institut für Pharmakologie und Toxikologie, Technischen Universität München.

出版信息

Fortschr Med. 1990 Sep 30;108(28):539-42.

PMID:2242840
Abstract

In the treatment of cardiac arrhythmias of varying genesis, an "observational study" in 1,160 patients showed that a high-dose oral magnesium preparation (Magnesium-Diasporal N 300 Granulat) was effective. In 82% of the patients observed, a dose of at least 300 mg magnesium/day produced good to very good results. Adverse effects of the drug were observed in only 1.6% of the patients. For all groups, the "success parameters" improved significantly. High-rate arrhythmias showed a better response to magnesium treatment than did low-rate arrhythmias, with a close correlation being found with the heart rate at the start of treatment. High-dose oral magnesium had a positive effect on concomitant hypertension. At a dosage of 300 mg treatment should be continued for at least 6 weeks.

摘要

在对不同病因的心律失常进行治疗时,一项针对1160名患者的“观察性研究”表明,高剂量口服镁制剂(镁泻盐N 300颗粒)是有效的。在观察的患者中,82%的患者每天服用至少300毫克镁产生了良好到非常好的效果。仅1.6%的患者观察到该药物的不良反应。对于所有组,“成功参数”均有显著改善。高心率心律失常对镁治疗的反应比低心率心律失常更好,且与治疗开始时的心率密切相关。高剂量口服镁对伴发的高血压有积极作用。剂量为300毫克时,治疗应持续至少6周。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验